1. Home
  2. ZYME vs WABC Comparison

ZYME vs WABC Comparison

Compare ZYME & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$26.58

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

HOLD

Current Price

$48.15

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
WABC
Founded
2003
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ZYME
WABC
Price
$26.58
$48.15
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$28.00
$52.00
AVG Volume (30 Days)
1.9M
125.1K
Earning Date
11-06-2025
01-15-2026
Dividend Yield
N/A
3.83%
EPS Growth
N/A
N/A
EPS
N/A
4.59
Revenue
$134,481,000.00
$264,660,000.00
Revenue This Year
$65.21
N/A
Revenue Next Year
$20.39
N/A
P/E Ratio
N/A
$10.45
Revenue Growth
116.21
N/A
52 Week Low
$9.03
$42.00
52 Week High
$28.49
$58.24

Technical Indicators

Market Signals
Indicator
ZYME
WABC
Relative Strength Index (RSI) 73.43 51.51
Support Level $21.89 $47.41
Resistance Level $28.49 $50.04
Average True Range (ATR) 1.53 1.22
MACD 0.65 0.12
Stochastic Oscillator 84.61 44.62

Price Performance

Historical Comparison
ZYME
WABC

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About WABC Westamerica Bancorporation

Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.

Share on Social Networks: